Results 21 to 30 of about 2,493,291 (257)

How Can We Best Diagnose Severity Levels of Dry Eye Disease: Current Perspectives [Corrigendum]

Clinical Ophthalmology, 2023
Chester T, Garg S, Johnston J, Ayers B, Gupta P. Clin Ophthalmol. 2023;17:1587–1604. Page 1587, author list, the text “Brandon Ayers” should read “Brandon Ayres”.
Chester T, Garg S, Johnston J, Ayers B, Gupta P   +4 more
doaj   +1 more source

A prospective, multicenter, noninterventional study of Optive Plus® in the treatment of patients with dry eye: the prolipid study

Clinical Ophthalmology, 2014
Thomas Kaercher,1 Ulrich Thelen,2 Gerrett Brief,3 Robert J Morgan-Warren,4 Richard Leaback41Augenarztpraxis, Heidelberg, Germany; 2University of Münster, Münster, Germany; 3Ruhr University, Bochum, Germany; 4Allergan Holdings Ltd, Marlow, UK ...
Kaercher T, Thelen U, Brief G, Morgan-Warren RJ, Leaback R   +4 more
doaj   +1 more source

Treatment of severe dry eye following acoustic neuroma surgery with eyelid androgen gel application

American Journal of Ophthalmology Case Reports
Purpose: To report a case of recalcitrant dry eye disease caused by acoustic neuroma and subsequent microsurgery. Observations: A 51-year-old female presented with refractory unilateral (right eye) severe dry eye disease (DED).
Jay Ruzhang Jiang, Rima Khankan, William H. Ridder, III, Jerry R. Paugh   +3 more
doaj   +2 more sources

Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial

Clinical Ophthalmology, 2015
Peter A Simmons, Cindy Carlisle-Wilcox, Joseph G Vehige Ophthalmology Research and Development, Allergan, Inc., Irvine, CA, USA Background: Dry eye may be caused or exacerbated by deficient lipid secretion.
Simmons PA, Carlisle-Wilcox C, Vehige JG
doaj   +1 more source

Presence of Histatin-1 in Human Tears and Association with Aqueous Deficient Dry Eye Diagnosis: A Preliminary Study. [PDF]

Sci Rep, 2019
The aims of this study were to determine if histatin-1 (H1) is present in normal human tears and whether tear levels of H1 varied between normal patients and those with aqueous deficient dry eye disease (ADDE).
Kalmodia S, Son KN, Cao D, Lee BS, Surenkhuu B, Shah D, Ali M, Balasubramaniam A, Jain S, Aakalu VK.   +9 more
europepmc   +2 more sources

Gut–ocular surface axis in dry eye disease: phenotype-specific mechanisms, evidence, and microbiome-targeted interventions [PDF]

Frontiers in Cellular and Infection Microbiology
Dry eye disease is a multifactorial, heterogeneous ocular surface disorder characterized primarily by an imbalance in tear film homeostasis. The traditional classification into “aqueous deficiency” and “evaporative” types fails to fully account for the ...
Zhizi Zhang, Zhizi Zhang, Zhizi Zhang, Dandan Liao, Lifeng Zhao, Lifeng Zhao, Lifeng Zhao, Xuejing Lu, Xuejing Lu, Xuejing Lu   +9 more
doaj   +2 more sources

Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED). [PDF]

BMC Ophthalmol, 2015
Dry eye disease (DED) affects millions of people worldwide. There are a variety of new treatments beyond traditional therapies such as preservative free artificial tears. Here, we conduct a survey to identify the most common treatments used among specialists and assess their interest in newer therapies.An international survey was distributed to dry eye
Sy A, O'Brien KS, Liu MP, Cuddapah PA, Acharya NR, Lietman TM, Rose-Nussbaumer J.   +6 more
europepmc   +4 more sources

Association of rheumatoid arthritis with aqueous deficient dry eye development

SSRN Electronic Journal, 2022
Abstract Purpose: to evaluate rheumatoid arthritis (RA) as a potential risk factor for the development of aqueous deficient dry eye (ADDE) compared to evaporative dry eye (EDE). Study Design: The study design was observational and cross-sectional. Methods: Two hundred volunteer participants with dry eye disease (DED) were recruited based on the
Hugo Pena-Verdeal, Jacobo Garcia-Queiruga, Belén Sabucedo-Villamarin, Carlos Garcia-Resua, Maria J. Giraldez, Eva Yebra-Pimentel   +5 more
openaire   +1 more source

Management of corneal perforations in dry eye disease: Preferred practice pattern guidelines

Indian Journal of Ophthalmology, 2023
Corneal perforations in eyes with dry eye disease (DED) are difficult to manage due to the interplay of several factors such as the unstable tear film, surface inflammation, and the underlying systemic disease affecting the wound healing process, and the
Anahita Kate, Rashmi Deshmukh, Pragnya R Donthineni, Namrata Sharma, Rasik B Vajpayee, Sayan Basu   +5 more
doaj   +1 more source

Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease. [PDF]

Invest Ophthalmol Vis Sci, 2014
Lacritin is a tear glycoprotein with prosecretory, prosurvival, and mitogenic properties. We examined lacritin levels in the tears of Sjögren's syndrome (SS) patients and explored the therapeutic potential of topical lacritin for the treatment of keratoconjunctivitis sicca.Tears from healthy controls (n = 14) and SS patients (n = 15) were assayed for ...
Vijmasi T, Chen FY, Balasubbu S, Gallup M, McKown RL, Laurie GW, McNamara NA.   +6 more
europepmc   +4 more sources